MiNK Therapeutics
UK - CambridgeBiotechnology
Focus: MiNK Therapeutics is a UK-based cell therapy biotech specializing in CAR-T and gene therapy approaches for hematologic malignancies and solid tumors. The company is early-stage with a focused pipeline in Phase 1 development.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
Open Jobs
0
About MiNK Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow MiNK Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
agenT-797
Tumor, SolidClinical Trials (1)
NCT05108623A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors
Phase 1Help build intelligence for MiNK Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.